3/10
05:01 pm
glpg
Galapagos Receives Transparency Notifications from Bank of America
Low
Report
Galapagos Receives Transparency Notifications from Bank of America
3/6
04:44 pm
glpg
Galapagos Creates New Subscription Right Plan [Yahoo! Finance]
Low
Report
Galapagos Creates New Subscription Right Plan [Yahoo! Finance]
3/6
04:01 pm
glpg
Galapagos Creates New Subscription Right Plan
Low
Report
Galapagos Creates New Subscription Right Plan
3/5
04:31 pm
glpg
Galapagos Appoints Tania Philipp as Chief Human Resources Officer [Yahoo! Finance]
Low
Report
Galapagos Appoints Tania Philipp as Chief Human Resources Officer [Yahoo! Finance]
3/5
04:01 pm
glpg
Galapagos Appoints Tania Philipp as Chief Human Resources Officer
Low
Report
Galapagos Appoints Tania Philipp as Chief Human Resources Officer
3/4
04:31 pm
glpg
Galapagos Receives Transparency Notifications from Bank of America [Yahoo! Finance]
Low
Report
Galapagos Receives Transparency Notifications from Bank of America [Yahoo! Finance]
3/4
04:01 pm
glpg
Galapagos Receives Transparency Notifications from Bank of America
Low
Report
Galapagos Receives Transparency Notifications from Bank of America
2/27
06:13 pm
glpg
Galapagos (GLPG) was upgraded by
Weiss Ratings from "sell (d)" to "hold (c)".
Low
Report
Galapagos (GLPG) was upgraded by
Weiss Ratings from "sell (d)" to "hold (c)".
2/24
07:10 pm
glpg
Galapagos NV (GLPG) Full Year 2025 Earnings Call Highlights: Strategic Shifts and Financial ... [Yahoo! Finance]
Low
Report
Galapagos NV (GLPG) Full Year 2025 Earnings Call Highlights: Strategic Shifts and Financial ... [Yahoo! Finance]
2/24
07:01 pm
glpg
Galapagos (GLPG) had its "sector perform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
Galapagos (GLPG) had its "sector perform" rating reaffirmed by Royal Bank Of Canada.
2/24
12:05 pm
glpg
Galapagos (NASDAQ:GLPG) had its "market perform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Galapagos (NASDAQ:GLPG) had its "market perform" rating reaffirmed by analysts at Raymond James Financial, Inc..
2/24
12:05 pm
glpg
Galapagos (NASDAQ:GLPG) had its "market perform" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Galapagos (NASDAQ:GLPG) had its "market perform" rating reaffirmed by analysts at UBS Group AG.
2/23
04:01 pm
glpg
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Low
Report
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
2/19
04:01 pm
glpg
Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors
Low
Report
Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors
2/16
04:01 pm
glpg
Galapagos Receives Transparency Notification from Bank of America
Low
Report
Galapagos Receives Transparency Notification from Bank of America
2/10
04:01 pm
glpg
Galapagos Receives Transparency Notifications from Bank of America
Low
Report
Galapagos Receives Transparency Notifications from Bank of America
1/5
04:01 pm
glpg
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
Low
Report
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
12/30
01:07 am
glpg
Low
Report
12/22
05:42 am
glpg
Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation [Seeking Alpha]
Low
Report
Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation [Seeking Alpha]
12/22
01:07 am
glpg
12/18
04:36 pm
glpg
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus [Yahoo! Finance]
Medium
Report
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus [Yahoo! Finance]
12/18
04:01 pm
glpg
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Medium
Report
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
12/14
01:26 am
glpg
Low
Report